136 related articles for article (PubMed ID: 35116865)
41. Expression and prognostic significance of long noncoding RNA AK001796 in esophageal squamous cell carcinoma.
Zong MZ; Shao Q; An XS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):181-186. PubMed ID: 30657559
[TBL] [Abstract][Full Text] [Related]
42. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
43. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
44. [Survival and the value of adjuvant chemotherapy in esophageal squamous cell carcinoma patients with lymphatic metastasis].
Qi Z; Wang YX; Yang Q; Li J; Yao JF; He M
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):628-633. PubMed ID: 28835088
[No Abstract] [Full Text] [Related]
45. The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Wang YM; Lo CM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
Oncotarget; 2017 Nov; 8(56):96190-96202. PubMed ID: 29221198
[TBL] [Abstract][Full Text] [Related]
46. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
47. Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy.
Duan XF; Tang P; Shang XB; Jiang HJ; Yu ZT
Oncotarget; 2017 Oct; 8(49):86908-86916. PubMed ID: 29156845
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy of adjuvant therapy in 110 patients with N1 lymph node metastasis of esophageal squamous cell carcinoma].
Shao G; Guo Y; Wang X; Zhang H; Cui Y; Liang T; Ma K
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):55-62. PubMed ID: 26796808
[TBL] [Abstract][Full Text] [Related]
49. Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma.
Li L; Ma G; Jing C; Liu Z
Discov Med; 2015 Dec; 20(112):369-78. PubMed ID: 26760981
[TBL] [Abstract][Full Text] [Related]
50. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
51. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
[TBL] [Abstract][Full Text] [Related]
52. Lack of any prognostic value of body mass index for patients undergoing chemoradiotherapy for esophageal squamous cell carcinoma.
Zhang F; Wang CS; Sun B; Tian GB; Cao FL; Cheng YF
Asian Pac J Cancer Prev; 2014; 15(7):3075-9. PubMed ID: 24815450
[TBL] [Abstract][Full Text] [Related]
53. Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
Zhang W; Pang Q; Zhang X; Yan C; Wang Q; Yang J; Yu S; Liu X; Pan Y; Yuan Z; Wang P; Xiao Z
Cancer Sci; 2017 Apr; 108(4):590-597. PubMed ID: 28192623
[TBL] [Abstract][Full Text] [Related]
54. The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis.
Deng X; He W; Jiang Y; Deng S; Mao T; Leng X; Luo Q; Zheng K; Han Y
Ann Transl Med; 2021 Jun; 9(12):998. PubMed ID: 34277798
[TBL] [Abstract][Full Text] [Related]
55. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
56. Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients.
Ma Q; Liu W; Jia R; Long H; Zhang L; Lin P; Zhao H; Ma G
Oncotarget; 2016 Jun; 7(25):38857-38863. PubMed ID: 27095577
[TBL] [Abstract][Full Text] [Related]
57. Lymph Node Metastases Diagnosed by
Ogino I; Watanabe S; Misumi T; Hata M; Kunisaki C
Anticancer Res; 2019 Sep; 39(9):4977-4985. PubMed ID: 31519604
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
60. Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.
Zhang G; Zhang Q; Zhang Q; Yin L; Li S; Cheng K; Zhang Y; Xu H; Wu W
J Cancer Res Clin Oncol; 2010 Apr; 136(4):587-94. PubMed ID: 19823871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
